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article under the CC BY-NC-ND license (Abstract Background/purpose: In the oral environment, Candida albicans interacts with many
bacteria, including Enterococcus faecalis.We investigated the susceptibility ofC. albicansbiofilm
development to the presence of unencapsulated E. faecalis cps2 in comparison with reference
strains (E. faecalis ATCC 29212) or their respective spent medium (collected at 6 hours).
Material and methods: Crystal violet stain was used to measure the total biofilm mass, whereas
quantitative real-time polymerase chain reaction was used to analyze the change in expression
of the mRNA of hypha morphology (ALS1 and ALS3) and biofilm maturation (EFB1).
Results: At the intermediate stage, C. albicans resisted the presence of each E. faecalis strain
tested and their spent medium. However, at the maturation stage, the unencapsulated strain
was stronger in reducing C. albicans biofilms than the reference strain (P< 0.05). At this matura-
tion stage, the transcription levels of each gene tested decreased in the presence of either E. fae-
calis strains or their respective spentmedium. Theunencapsulated strainwasmore pronounced in
reducing ALS1/ALS3 expression, whereas the respective spent medium had a similar capability to
restrict the expression of EFB1.
Conclusion: This study showed, the unencapsulated strain is more effective in inhibiting C. albi-
cans biofilm development compared with the reference strains. In contrast, the secreted mole-
cules producedbyeach strain testedarenecessary in controlling thegrowths ofC. albicansbiofilm.
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324 E.W. Bachtiar et alIntroductionFigure 1 Stain-all staining of heat extracts of different
Enterococcus faecalis strains after electrophoresis in an acryl-
amide gel. Lanes: 1Z prestained protein markers (New England
BioLabs); 2Z reference strain (ATCC29212); 3ZencapsulatedE.
faecalis cps2 (strain that showed no positive result after qPCR);
4Zunencapsulated cps2 (strain that showedpositive result after
qPCR). The arrow indicates locations of CPS. CPS Z capsular
polysaccharide; qPCRZquantitative polymerase chain reaction.Enterococcus faecalis is a Gram-positive bacterium that has
the ability to colonize a variety of sites in humans, including
the oral niche.1 Like E. faecalis, Candida albicans is a fungal
species that exists in many niches in the human body,
including the gastrointestinal tract and the oral cavity. Both
organisms are often found as coisolates in samples collected
from endodontic-related infections, especially those linked
with chronic periodontitis, as well as from root-filled teeth
with periapical lesions.2 This indicates that conditions in
root canal teeth favoring infection with either are similar.
A report by Pinheiro et al3 showed that the majority of E.
faecalis isolates taken from root canal teeth were of the CPS
(capsular polysaccharide) type 1 (cps1) genotype. However,
a report byour group4 found that thedominant strain found in
saliva and infected root canals is the E. faecalis cps2 geno-
type, a strain belonging to serotype C,5 and its virulent traits
are associated with the presence of the surface CPS.6 This
indicates that in infected root canal teeth, the E. faecalis
cps2 strain may differ from those in other oral niches.
Moreover, a previous report showed that E. faecalisQA29b (a
nonstarter food isolate) is an incongruent cps2 strain. This
strain carries the full-length cps2 locus, but its cps gene is not
expressedbecauseof an insertion sequence, IS6770, inserted
in the cpsCecpsK promoter region.7 Thus, the presence of
IS6770 suggests that at some points the nonencapsulated
phenotypemay be advantageous during some points in the E.
faecalis life cycle and disadvantageous at others, suggesting
a role in its adaptation. Because C. albicans and E. faecalis
have shown antagonistic relationships in the Caenorhabditis
elegans model,8 where E. faecalis inhibits hyphal formation
of C. albicans, we hypothesized that the absence of the cps
expression could enable the bacterium to communicate with
C. albicans through antagonistic interactions while the fun-
gus grows as biofilm.
A number of studies have also described changes in gene
expression levels during biofilm development of C.
albicans.9e11 Of these, ALS1 and ALS3, which belong to the
ALS (agglutinin-like sequence) gene family, encodes cell
surface glycoproteins.12,13 Another gene, EFB1, has been
reported to be constitutively expressed under most growth
conditions of C. albicans.14 All genes have been demon-
strated to be upregulated in C. albicans hyphae, which sug-
gests that theymay play a role in biofilm development by this
organism.13,15,16 Considering the above-mentioned infor-
mation, we used an unencapsulated E. faecalis cps2 strain,
based on the presence of IS6770, to investigate its effect on
C. albicans growth and biofilm formation in vitro. For this
reason, we used crystal violet (CV) assays to measure the
biofilmmass and the quantitative polymerase chain reaction
(qPCR) method to evaluate the altered mRNA expression of
the ALS1, ALS3, and EFB1 genes. Analysis of the in vitro
interaction of E. faecalis and C. albicans may contribute to
the understanding of the behavior of the unencapsulated E.
faecalis cps2 strain in the human body environment.
Materials and methods
The unencapsulated E. faecalis cps2 strain used in this study
was a clinical isolate. This strain was isolated from one of theendodontic patients in our previous study.4 PCR5 and qPCR
methods were used to determine CPS genotyping character-
ization and todetermine theencapsulated or unencapsulated
strain by detecting the presence of the insertion sequence
(IS6770).7 To visualize the presence or absence of the CPS,
expressed by this strain, we used the staining method, stain-
All (Sigma-Aldrich, St. Louis, MO, USA) (Figure 1).17 E. faecalis
strain ATCC 29212 was used as a control during testing. All E.
faecalis strainsweremaintained inbraineheart infusion (BHI)
broth (Oxoid, Basingstoke, United Kingdom) with 30% (v/v)
glycerol at 80C until testing.
C. albicans used in this study was C. albicans ATCC 10231
that was routinely propagated in yeast extrac-
tepeptoneedextrose (YPD; 1% yeast extract, 2% peptone,
2% glucose) agar plates or, when indicated, in yeast nitro-
gen base (YNB; Difco Laboratories, Detroit, MI, USA) me-
dium (pH 7), supplemented with 50mM glucose.
To obtain spent medium samples, we used a method as
described previously.18 E. faecalis was grown in 20 mL BHI
broth. Then, 10 mL of the medium was taken from over-
night cultures at a middle exponential stage of growth
(6 hours) and centrifuged at 5000 g, 10 minutes (Thermo
Fisher Scientific, Waltham, MA, USA). The supernatant was
filter sterilized through a 0.22-mm filter (Millipore, Billerica,
MA, USA). Protein concentration in the spent medium was
determined using the Bradford method. Spent medium was
diluted in phosphate buffer saline (PBS; Sigma-Aldrich) to
yield 10 mg/mL and 100 mg/mL concentrations and used
immediately or stored for short periods at 20C. The pH of
the spent medium was adjusted to pH 7.
Biofilm staining with CV and the colony-forming
unit assay
For the biofilm assay, yeast cells of C. albicans were grown
overnight at 35C. After incubation for 16 hours at 37C with
E. faecalis cps2 inhibits C. albicans biofilm 325aeration in YNB, cells were harvested via centrifugation
(5000g, 5 minutes) and then suspended in YNB adjusted to
an optical density at 600 nm of 0.2 (OD600 Z 0.2). C. albi-
cans biofilm was grown on 96-well microtiter plates (Iwaki,
Tokyo, Japan) that were previously coated with human
salivary proteins (1 hour at 37C).19 Plates were first incu-
bated for 90 minutes with a cell suspension containing
1.8  106 cells/mL, counted using a hemacytometer, and
then washed twice with PBS to remove nonadherent yeast
cells. For mature biofilms to develop, 100 mL fresh YNB
medium was added and the plates were incubated at 37C
for 24 hours and 48 hours at 30C. Following incubation,
media containing dispersal cells were discarded and the
wells were washed three times with 150 mL sterile PBS. The
biofilms were then stained with 100 mL (1%) CV (Sigma-
Alrich) for 15 minutes. They were then washed three times
with PBS to remove unbound CV dye and dried at room
temperature. The stains were released from the biofilms by
adding 1 mL absolute ethanol, and the wells were incubated
on a rocking platform for 20 minutes at room temperature.
Absorbance was recorded at 590 nm. Each biofilm assay was
run in triplicate, and the means  standard deviations of
three separate experiments were calculated and plotted.
E. faecalis from culture stock was grown in BHI agar
(Oxoid) overnight at 37C, and was harvested via centrifu-
gation (5000g, 10 minutes). The bacterium was subse-
quently grown aerobically in liquid medium containing 70%
YNB and 30% BHI (vol/vol) for 16 hours. To test the capa-
bility of E. faecalis to inhibit biofilm mass and the expres-
sion of ALS1, ALS3, and EFB1 genes expressed by C. albicans
biofilm, 100 mL of a suspension-containing bacterium
[2  107 colony-forming units (CFU)/mL] was added into
microtiter plates containing C. albicans biofilm. The CV
assay was performed as described above after each incu-
bation period (24 hours and 48 hours). Alternatively, for
assays in which only E. faecalis spent medium was used, the
30% BHI fraction was replaced by sterile spent medium
prepared as mentioned above. C. albicans biofilms added to
PBS (pH 7.2) instead of E. faecalis cells or its spent media
were included to serve as negative controls. Each assay was
performed in triplicate and repeated in two independent
experiments.
In addition to the CV assay, the CFU assay was used to
estimate the viable number of C. albicans cells. For this
assay, 10-fold serial dilutions in PBS were made, and the
number of CFU was determined by plating the yeast cells
from 100-mL aliquots onto YPD agar, which contained
gentamicin sulfate (50 mg/mL), to kill the bacterium. The
number of colonies (CFU/mL) was counted after the cells
were incubated for 48 hours at 37C under aerobic
conditions.Quantitative real-time PCR
The mRNA expression changes of ALS1/ALS3 and EFB1 in
response to the tested E. faecalis strain or its respective
spent medium were assessed using qPCR. To do this, C.
albicans 24-hour and 48-hour biofilms were used for the
isolation of total RNA (RNeasy Mini kit; Qiagen, Valencia,
CA, USA). Then, 3 mg RNA was treated with DNase I (TaKaRa
Bio, Tokyo, Japan) and used for cDNA synthesis using theTaqMan Reverse Transcription kit (Applied Biosystems,
Foster City, CA, USA). The resulting cDNA was further
diluted 1:5 with sterile MilliQ water. The cDNA was
conserved at 80C until used.
To quantify cDNAs (which had been synthesized from RNA
as described above), we used primers that previous studies
showed to correspond to C. albicans ALS1, ALS3,20 and
EFB1.14 The PCR mix contained 5 mL template-diluted cDNA,
100nM of forward and reverse primers, Platinum SYBR Green
qPCR SuperMix-UDG (Invitrogen Life Technologies, Carlsbad,
CA, USA), and passive reference (ROX; Invitrogen). The final
volume was 25 mL. PCR reactions were run on The ABI
StepOnePlus Real-Time PCR Systems with conditions
including a 10-minute denaturation step at 95C followed by
40 cycles of 95C (15 seconds) and 60C (1 minute). The melt
curve profile was as follows: 95C for 15 seconds, 60C for
60 seconds, and 95C for 15 seconds. In this study, the ACT1
was used for the normalization of qPCR data.21 The formula,
fold change Z 2eDDCt, was used to calculate, ALS1, ALS3,
and EFB1 expression levels,22 at the different time intervals
set in this study during biofilm formation relative to the
expression in the negative control (C. albicans ATCC 10231).
The Ct values were provided from qPCR instrumentation and
were imported into a Microsoft Excel 2010 spreadsheet. The
experiment was carried out in triplicate, and three inde-
pendent experiments were performed. The collected data
were expressed as mean  standard deviation, and the
mean quantitative gene expression patterns were compared
via Student t test using the SPSS Win 12.0 program (SPSS
Inc., Chicago, IL, USA). A P value < 0.05 was considered
statistically significant.
Results
Different effects of unencapsulated E. faecalis cps2
and its spent medium on the biomass and viability
of C. albicans as biofilm
In this study, the E. faecalis cps2 type was determined as an
unencapsulated strain by using qPCR,7 and the result was
visually confirmed by All-stain (SigmaeAldrich, St. Louis,
MO, USA) (Figure 1). The unencapsulated strain was further
tested for its effect on the susceptibility of C. albicans
biofilm growth in intermediate (24-hour) and mature
development (48-hour) phases, whereas E. faecalis ATCC
29212 was used as a reference strain. As shown in Figures
2A and 2B, in comparison to the control, neither E. faeca-
lis strains tested nor their spent medium had any inhibitory
effect on preadhered C. albicans biofilms after the inter-
mediate phase (P > 0.05). After a prolonged incubation
time (48 hours), only the unencapsulated strain was suffi-
cient to reduce biofilm mass (P < 0.001). At this maturation
stage, the number of viable cells detected within this bio-
film was significantly reduced by approximately 50%,
compared with the control (P < 0.005), because of the
addition of spent medium produced by either unencapsu-
lated E. faecalis cps2 or the reference strain ATCC 29212.
Our data also found that 10 mg/mL protein concentration of
the spent medium was sufficient to reduce biofilm mass,
and a similar trend was observed when using a higher pro-
tein concentration (100 mg/mL; not shown). We also
Figure 2 Effects of unencapsulated Enterococcus faecalis cps2 or E. faecalis reference strain (ATCC 29212) or their respective
spent medium, which contains 10 mg/mL protein, on established Candida albicans ATCC 10231 biofilms and cell viability within the
biofilms. After each time point (24 hours and 48 hours). (A) Biofilm masses were quantified using crystal violet staining and (B)
viability cell within the remaining biofilms were assessed using CFU evaluation. Data are means  standard deviations of three
independent experiments performed in triplicate. * Statistical significance (P < 0.05) of observed differences between each time
point. CFUZ colony-forming unit; ODZ optical density; SM-ATCC 29212Z spent medium of the reference strain; SM-UEsZ spent
medium of unencapsulated E. faecalis strain; UEs Z unencapsulated E. faecalis strain.
326 E.W. Bachtiar et alobserved that untreated 48-hour biofilms (controls) of C.
albicans generated a higher biomass than their 24-hour
counterparts; however, this increase was not significant
(P > 0.05). Furthermore, comparisons between 24-hour and
48-hour biofilms treated with the E. faecalis strains tested
or their spent medium did show a significant difference in
reducing total biomass (P < 0.05). In parallel, the viability
of cells remaining in the biofilm measured using the CFU
assay showed that, in general, cell viability decreased in
proportion to the elimination of biofilm biomass for each
time point measurement (Figure 2B).Figure 3 ALS1, ALS3, and EFB1 gene expression levels at
different time points (24 hours and 48 hours) during Candida
albicans biofilm development in the presence of unencapsu-
lated Enterococcus faecalis cps2 or E. faecalis ATCC 29212.
Data are shown as the fold regulation calculated using the
comparative Ct method. The tested genes were normalized to
the ACT1 gene level. * Indicates a statistically significant dif-
ference (P < 0.05) in reducing EFB1 gene between the E.
faecalis strains tested after 48 hours. UEsZ unencapsulated E.
faecalis strain.Different effects of unencapsulated E. faecalis cps2
and its spent medium on the expression of ALS1,
ALS3, and EFB1 in C. albicans biofilm
Based on the data of measuring C. albicans biofilm mass, we
sought to determine whether the capacity of the bacterium
tested and its spent medium in inhibiting biofilm formation
took place through the regulation of certain biofilm-related
genes. As shown in Figure 3, when each E. faecalis strain
tested was added to C. albicans biofilm for 24 hours, the
expression of each gene had greater than onefold upregu-
lation in comparison with biofilm control without E. faecalis
(P < 0.05). Interestingly, a similar trend in the expression of
ALS1 and ALS3 genes was observed against the 48-hour
biofilm in our system. By comparing to the intermediate
stage (24 hours), the transcription level of these hyphae-
specific genes was decreased progressively (P < 0.05). For
EFB1, our data showed that the unencapsulated E. faecalis
cps2 strain had a stronger capacity in reducing this gene
(>60%) after the 48-hour incubation time, compared withthe reference strain (ATCC 29212) that showed <10% ability
(P < 0.05).
To uncover whether the spent medium from each of
these strains had an effect in reducing the ability of C.
E. faecalis cps2 inhibits C. albicans biofilm 327albicans to grow as biofilms, we assessed the expression of
all three genes mentioned above of C. albicans biofilm
grown in YPD medium containing spent medium from each
E. faecalis strain tested. We observed that after 24 hours,
irrespective of the source of the spent medium, more than
twofold increases in ALS1, ALS3, and EFB1 expression levels
were recorded, compared with that observed in the con-
trols (P < 0.05). However, a 48-hour exposure of the can-
didal biofilm to the spent medium resulted in minimal
effects on induction of the expression of ALS1 and ALS3
(Figure 4). Their transcription levels were comparable with
those of the negative control. The expression of EFB1 was
also modulated by spent medium. Figure 4 shows that the
added spent medium led to more than a 40% decrease in the
transcription level of EFB1 mRNA. Statistical analysis
showed that either spent medium derived from unencap-
sulated or reference strain had a stronger effect in down-
regulating the EFB1 gene in C. albicans biofilm cells,
compared with the control (P < 0.05).
Discussion
Biofilm formation and the inhibition of C. albicans growth
by oral bacteria are a general phenomenon in the oral
ecosystem,23 and together with E. faecalis, this fungus is
often present in root canal infections as persistent micro-
organisms.24 A previous study reported that E. faecalis cps1
strain, a non-CPS phenotype, is the more common isolate
found in canals of root-filled teeth with periapical lesions.3
This result appears to contradict our findings,4 wherein we
found that E. faecalis cps2 is a dominant strain isolated
from clinical oral samples. In our study, we also found that
genetic diversity within E. faecalis isolates, as revealed
with Enterobacterial Repetitive Intergenic consensus
(ERIC)ePCR was not only found among different cps types,Figure 4 Spent medium, containing 10 mg/mL protein, from
unencapsulated Enterococcus faecalis cps2 strain or E. faecalis
ATCC 29212 that was added into Candida albicans biofilm for
24 hours and 48 hours, respectively. Means of ALS1, ALS3, and
EFB1 transcription level were deduced from three separate
experiments is presented with SD. * Indicates statistically sig-
nificant (P < 0.05) difference between transcription level of the
EFB1 genes in C. albicans biofilm, compared with the negative
control. SD Z standard deviation; UEs Z unencapsulated E.
faecalis strain.but also among isolates belonging to the same cps type,
including cps2. In the current study, we demonstrated that
the silencing of cps2 genes in our E. faecalis clinical isolate
was attributable to the presence of IS6770. This corrobo-
rates earlier findings that the CPS phenotype may not
necessarily be expressed in an E. faecalis cps2 genotype.7
Because E. faecaliseC. albicans interactions have po-
tential implications in the oral ecosystem,25 we assumed
that the observed difference in CPS phenotype within E.
faecalis strains tested may have a different effect on C.
albicans, when the fungus is growing as biofilm. Therefore,
in the current study, we assessed the effect of the presence
of the clinical isolates of E. faecalis cps2, unencapsulated
strain or its spent medium, on the formation of C. albicans
biofilms on microtiter plate in vitro. The E. faecalis refer-
ence strain (ATCC 29212), which shows encapsulated
phenotype (Figure 1), is needed for the evaluation and
validation of the assay.
When taken individually, each type of E. faecalis strain
tested here had significant effects, either inhibitory or
stimulatory, on C. albicans biofilm formation. When the
phase of biofilm development was evaluated, both E. fae-
calis strains tested showed a similar stimulating effect at
the intermediate phase (24 hours), with no apparent
antagonism on C. albicans biofilm, indicating the ability of
the bacteria and yeasts to coinhabit. It seems that at the
24-hour interval of biofilm development, the promoting
effect could be attributed to the presence of E. faecalis as
a source of peptidoglycan, which in turn triggers C. albicans
hyphal growth.26 Additionally, because E. faecalis produces
large amounts of extracellular superoxide,27 the presence
of this bacterium might induce a reactive oxidative stress-
stimulated filamentation of C. albicans.28 Thus, it is
important to emphasize that, in the presence of unencap-
sulated E. faecalis cps2, the number of C. albicans cells
increased in specific time points during the development of
the biofilm comparatively to control. However, at some
point, the relationship between these microorganisms be-
comes antagonistic. As shown in the current study, a
reduction on C. albicans cell viability was found after 48
hours following inoculation of the unencapsulated E. fae-
calis cps2 strain. This result highlights the capacity of the
unencapsulated E. faecalis cps2 strain to interfere with C.
albicans biofilm formation in a time-dependent manner.
Indeed, this result is indicative that the presence of IS6770
in the cps locus of unencapsulated E. faecalis cps2 strains
resulted in a greater ability to adhere to C. albicans, as
occurs when the bacterium interacts with epithelial cells.8
In contrast, bacteria cell products appear to have a
similar capacity in reducing C. albicans biofilm formation,
also in time-dependent fashion. As shown in Figure 2, each
bacterium spent medium substantially reduced the density
of candidal biofilm at the maturation stage along with the
amount of live cells, compared with the biofilm at the in-
termediate phase. This suggests that unlike their CPS phe-
notypes, spent medium (or active components therein)
produced by E. faecalis cps2 is inhibitory toward Candida
biofilm. This result is consistent with previously reported
experiments that the inhibitory effect is secreted rather
than cell associated.8 We further noted that the 10-mg/mL
protein concentration in spent medium produced by each
was enough to reduce the biofilm formation of C. albicans. A
328 E.W. Bachtiar et alsimilar trend was found at the higher protein concentrations
(100 mg/mL, not shown), indicating the spent medium effect
was not dependent on the protein concentration used.
To complement all of these data, we also aimed to
determine how these bacteria affect the differential
expression of C. albicans biofilm-related genes (ALS1, ALS3,
and EFB1) in biofilms. The proteins produced by ALS1 and
ALS3 genes are highly expressed in vitro.13 Both ALS1 and
ALS3 are key adhesins for biofilm formation by C. albi-
cans,11 and they play important roles during biofilm
development.10,29 The EFB1 gene is constitutively
expressed under most growth conditions and is frequently
used as a normalization gene in the real-time PCR quanti-
fication30,31 of other Candida genes. This gene is appro-
priate to quantitatively measure the damaging effects of
antifungal agents against mature biofilms.14
In this study, we observed consistent results between the
expression of the cell wall adhesins ALS1/ALS3, which were
upregulated in the intermediate stage (24 hours), and
stimulating effect for biofilm formation, an adhesin-
dependent phenotype of C. albicans.11,15 The stimulating
effect decreased significantly after prolonged incubation
(48 hours; P< 0.05). However, at this maturation phase, the
transcription levels of ALS1 and ALS3 mRNA were compara-
ble with the control (Figure 3). This reveals that, at the in-
termediate stage, hypha formation, which is favorable for C.
albicans adhesion, and biofilm formation32,33 are not spe-
cifically sensitive to the bacteria.8 However, at the matu-
ration stage, the fungus failed to offset the biofilm formation
inhibition caused by the presence of E. faecalis strains used
in this study. Our data further show (Figure 3), at the
maturation stage, that the unencapsulated strain had a
stronger capacity to reduce the transcription level of EFB1
mRNA, compared with the reference strain that showed less
ability. In this case, we cannot yet say whether the re-
ductions observed at this maturation stagedthus the time
factordare a general phenomenon in C. albicans biofilm
formation, as suggested by Nailis et al.13
Collectively, these results indicate that the intermedi-
ate biofilm phase of C. albicans proved resistant to the
presence of each tested strains of E. faecalis. Neither the
presence of the bacteria strains nor their spent mediums
inhibit the expression of genes encoding ALS1 and ALS3,
which are proteins for adhesive properties.11,34 Thus, at
this time point, increased expression of the hypha-related
genes are associated with increased adherence to the mi-
crotiter plate and increased biofilm mass and cell counts.
Additionally, the stimulating effects of both encapsulated
and unencapsulated E. faecalis strains tested on Candida
biofilms were proven to depend on the application time. In
contrast to regulation in the intermediate biofilm phase,
the stimulating effects as well as regulation of ALS1 and
ALS3 genes were decreased significantly after 48 hours.
This means that in the presence of unencapsulated E.
faecalis cps2, C. albicans has a decreased ability to main-
tain the hyphal phenotype and grow into a mature biofilm,
which is indicated by the significantly decreased EFB1 gene
expression after the biofilm maturation stage (Figure 3).
In this study, we observed that after 24 hours, greater
than twofold increases in ALS1, ALS3, and EFB1 gene
expression levels were recorded when adhered C. albicans
was treated with spent medium derived from the tested E.faecalis strains, compared with those observed in the
controls. However, exposing the candidal biofilm to the
spent medium for a longer incubation time (48 hours)
resulted in minimal effects on inducing the expression of
ALS1 and ALS3 genes. Their transcription levels were
comparable with those of the negative control (Figure 4).
The EFB1 gene was also modulated by spent medium. The
added spent medium derived from either E. faecalis strain
led to a significant decrease in the transcription level of
EFB1 mRNA, compared with the control.
Based on the results described above, if the transcrip-
tion levels were positively associated with protein pro-
duction, our data might suggest that ALS1 and ALS3
proteins function in response to the presence of E. faecalis
tested or their respective spent medium at intermediate
stages of biofilm development. This was consistent with
the strain’s ability to induce the expression of biofilm
maturity marker, the EFB1 gene.14 Interestingly, at the
maturation phase, significantly reduced C. albicans bio-
films occurred, which is evident from the reduction of
biofilm mass and cell’s viability by unencapsulated E.
faecalis cps2 strain and of hypha-related genes (ALS1 and
ALS3) expression by both strains. At this maturation phase,
the presence of C. albicans appeared to protect E. faecalis
from cell death.8 Thus, the survival E. faecalis strains may
have the ability to produce secreted molecules, and
changed the environment. This resulted in retarding the
hypha formation, thus leading to the defect of biofilm
maturation as shown in this study by the reduction in
biofilm metabolic activity as indicated by decreased EFB1
gene transcription levels. In this case, the biofilm inhibi-
tion effect was not dependent on the bacteria CPS
phenotype. It could be attributable to the secreted sub-
stances as reported by Cruz et al,8 and which we did not
identify in this study. However, as both yeast and hyphal
forms of C. albicans are capable of biofilm formation,9 our
data are not able to explain whether the existence of E.
faecalis strains tested inhibited the growth of yeast or
hypha forms of C. albicans after the 48-hour incubation
period on the microtiter plate. In this matter, we are not
ruling out the possibility that the expression of hypha-
related genes is varied. It depends on which C. albicans
strain was examined.35 From a clinical perspective, our
data may suggest a potentiation effect of antifungals seen
with unencapsulated E. faecalis cps2. However, we do not
know if the antagonistic effect on C. albicans biofilm for-
mation is a common character of unencapsulated E. fae-
calis cps2 in oral infection, because the present study used
only the clinical strain isolated from one patient requiring
endodontic treatment. Additionally, the exact role of cps2
gene and CPS on the biofilm formation of C. albicans is not
clearly identified in the current study. Further investiga-
tion is necessary to compare the influence on the biofilm
formation of C. albicans between unencapsulated E. fae-
calis, which has the cps2 gene in the presence of IS6770,
and the encapsulated isogenic strain, which has the cps2
gene in the absence of IS6770.
Irrespective of the mechanism involved, the results of
the present work suggest that E. faecalis cps2 carrying the
IS6770 sequence is an unencapsulated phenotype. When
the bacterium interacts with C. albicans, it has a capacity
to inhibit the fungus as it develops as biofilm. The
E. faecalis cps2 inhibits C. albicans biofilm 329antagonistic effect relates to the process of biofilm matu-
ration, when the secreted molecules were produced.
Additional studies are necessary to fully understand the
complex relationship between unencapsulated E. faecalis
cps2 and C. albicans while the fungus grows as biofilm.
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